Synthesis, characterization and antimicrobial evaluation of ferrocene–oxime ether benzyl 1 H -1,2,3-triazole hybrids
A series of eight novel ferrocene–oxime ether benzyl 1 H -1,2,3 triazole hybrids 5a–h were designed and synthesized by employing Cu( i ) catalyzed azide–alkyne [3+2] cycloaddition (CuAAC) between ferrocenecarboxaldehyde oxime O -propargyl ether and benzyl azides. The alkyne, ferrocenecarboxaldehyde...
Gespeichert in:
Veröffentlicht in: | New journal of chemistry 2019-05, Vol.43 (21), p.8341-8351 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A series of eight novel ferrocene–oxime ether benzyl 1
H
-1,2,3 triazole hybrids
5a–h
were designed and synthesized by employing Cu(
i
) catalyzed azide–alkyne [3+2] cycloaddition (CuAAC) between ferrocenecarboxaldehyde oxime
O
-propargyl ether and benzyl azides. The alkyne, ferrocenecarboxaldehyde oxime
O
-propargyl ether
3
, was synthesized by converting ferrocenecarboxaldehyde
1
into ferrocenecarboxaldehyde oxime
2
with subsequent
O
-propargylation. All the ferrocenyl triazole derivatives are remarkably stable crystalline solids and were obtained in good yields. All the products were well characterized by means of various analytical and spectroscopic techniques. The electrochemical behavior of the synthesized ferrocene–oxime ether benzyl triazole hybrids was investigated. Further, the structure of one of the triazoles
5a
was unambiguously established by means of single-crystal X-ray diffraction study. All the triazole compounds have been screened for
in vitro
antimicrobial activity against two Gram-positive (
Bacillus subtilis
and
Staphylococcus aureus
) and two Gram-negative bacteria (
Escherichia coli
and
Klebsiella pneumoniae
), and one fungal (
Candida albicans
) microorganism. All the ferrocene–oxime ether benzyl 1
H
-1,2,3 triazole hybrids have shown moderate to good inhibitory activity against most of the tested bacterial and fungal strains in comparison with standard drugs. |
---|---|
ISSN: | 1144-0546 1369-9261 |
DOI: | 10.1039/C9NJ00660E |